These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20041441)

  • 1. Defective interfering viruses and their potential as antiviral agents.
    Marriott AC; Dimmock NJ
    Rev Med Virol; 2010 Jan; 20(1):51-62. PubMed ID: 20041441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy.
    Pelz L; Rüdiger D; Dogra T; Alnaji FG; Genzel Y; Brooke CB; Kupke SY; Reichl U
    J Virol; 2021 Nov; 95(24):e0117421. PubMed ID: 34550771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a purely clonal defective interfering influenza virus.
    Yamagata Y; Muramoto Y; Miyamoto S; Shindo K; Nakano M; Noda T
    Microbiol Immunol; 2019 May; 63(5):164-171. PubMed ID: 30997933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homologous interference mediated by defective interfering influenza virus derived from a temperature-sensitive mutant of influenza virus.
    Nayak DP; Tobita K; Janda JM; Davis AR; De BK
    J Virol; 1978 Oct; 28(1):375-86. PubMed ID: 702654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?
    Dimmock NJ; Easton AJ
    J Virol; 2014 May; 88(10):5217-27. PubMed ID: 24574404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its Genome.
    Kupke SY; Riedel D; Frensing T; Zmora P; Reichl U
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral.
    Dimmock NJ; Rainsford EW; Scott PD; Marriott AC
    J Virol; 2008 Sep; 82(17):8570-8. PubMed ID: 18579602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production.
    Frensing T; Pflugmacher A; Bachmann M; Peschel B; Reichl U
    Appl Microbiol Biotechnol; 2014 Nov; 98(21):8999-9008. PubMed ID: 25132064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloned Defective Interfering Influenza RNA and a Possible Pan-Specific Treatment of Respiratory Virus Diseases.
    Dimmock NJ; Easton AJ
    Viruses; 2015 Jul; 7(7):3768-88. PubMed ID: 26184282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the molecular mechanism of defective interfering RNA-mediated symptom attenuation in tombusvirus-infected plants.
    Havelda Z; Szittya G; Burgyán J
    J Virol; 1998 Jul; 72(7):6251-6. PubMed ID: 9621100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Defective Viruses on Infection and Immunity.
    Genoyer E; López CB
    Annu Rev Virol; 2019 Sep; 6(1):547-566. PubMed ID: 31082310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segment-specific noncoding sequences of the influenza virus genome RNA are involved in the specific competition between defective interfering RNA and its progenitor RNA segment at the virion assembly step.
    Odagiri T; Tashiro M
    J Virol; 1997 Mar; 71(3):2138-45. PubMed ID: 9032347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell culture-based production of defective interfering particles for influenza antiviral therapy.
    Wasik MA; Eichwald L; Genzel Y; Reichl U
    Appl Microbiol Biotechnol; 2018 Feb; 102(3):1167-1177. PubMed ID: 29204901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative effect of defective interfering RNA accumulation and helper virus attenuation is responsible for the persistent infection of Japanese encephalitis virus in BHK-21 cells.
    Park SY; Choi E; Jeong YS
    J Med Virol; 2013 Nov; 85(11):1990-2000. PubMed ID: 23861255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective interfering type A equine influenza virus (H3N8) protects mice from morbidity and mortality caused by homologous and heterologous subtypes of influenza A virus.
    Noble S; Dimmock NJ
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3485-91. PubMed ID: 7996140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incomplete avian influenza virus contains a defective non-interfering component.
    Carter MJ; Mahy BW
    Arch Virol; 1982; 71(1):13-25. PubMed ID: 7065901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMRT sequencing revealed the diversity and characteristics of defective interfering RNAs in influenza A (H7N9) virus infection.
    Lui WY; Yuen CK; Li C; Wong WM; Lui PY; Lin CH; Chan KH; Zhao H; Chen H; To KKW; Zhang AJX; Yuen KY; Kok KH
    Emerg Microbes Infect; 2019; 8(1):662-674. PubMed ID: 31084471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling the intracellular replication of influenza A virus in the presence of defective interfering RNAs.
    Laske T; Heldt FS; Hoffmann H; Frensing T; Reichl U
    Virus Res; 2016 Feb; 213():90-99. PubMed ID: 26592173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular stability of the interfering activity of a defective interfering influenza virus in the absence of virus multiplication.
    Cane C; McLain L; Dimmock NJ
    Virology; 1987 Aug; 159(2):259-64. PubMed ID: 3617499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected complexity in the interference activity of a cloned influenza defective interfering RNA.
    Meng B; Bentley K; Marriott AC; Scott PD; Dimmock NJ; Easton AJ
    Virol J; 2017 Jul; 14(1):138. PubMed ID: 28738877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.